Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 20495513)

1.

Pitavastatin: the newest HMG-CoA reductase inhibitor.

Watson KE.

Rev Cardiovasc Med. 2010 Winter;11(1):26-32.

PMID:
20495513
2.

Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.

Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R.

Diabetes Obes Metab. 2000 Dec;2(6):355-62.

PMID:
11225965
3.

New evidence on pitavastatin: efficacy and safety in clinical studies.

Teramoto T, Shimano H, Yokote K, Urashima M.

Expert Opin Pharmacother. 2010 Apr;11(5):817-28. doi: 10.1517/14656561003641990. Review.

PMID:
20201733
4.

Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes.

Saiki A, Murano T, Watanabe F, Oyama T, Miyashita Y, Shirai K.

J Atheroscler Thromb. 2005;12(3):163-8. Erratum in: J Atheroscler Thromb. 2005;12(4):235.

5.

Pitavastatin: a new HMG-CoA reductase inhibitor.

Wensel TM, Waldrop BA, Wensel B.

Ann Pharmacother. 2010 Mar;44(3):507-14. doi: 10.1345/aph.1M624. Epub 2010 Feb 23. Review.

PMID:
20179258
6.

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.

Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.

Clin Ther. 2007 Nov;29(11):2365-73.

PMID:
18158077
7.

Pitavastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia.

Ahmad H, Cheng-Lai A.

Cardiol Rev. 2010 Sep-Oct;18(5):264-7. doi: 10.1097/CRD.0b013e3181ebdb2f. Review.

PMID:
20699675
8.

Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia.

Sansanayudh N, Wongwiwatthananukit S, Putwai P, Dhumma-Upakorn R.

Ann Pharmacother. 2010 Mar;44(3):415-23. doi: 10.1345/aph.1M522. Epub 2010 Feb 23.

PMID:
20179259
9.
10.

Toward a role for statins in immunomodulation.

Mach F.

Mol Interv. 2002 Dec;2(8):478-80.

PMID:
14993398
11.
12.

Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.

Chong PH, Seeger JD.

Pharmacotherapy. 1997 Nov-Dec;17(6):1157-77. Review.

PMID:
9399600
13.

Pitavastatin - results from phase III & IV.

Betteridge J.

Atheroscler Suppl. 2010 Dec;11(3):8-14. doi: 10.1016/S1567-5688(10)71064-3. Review.

PMID:
21193153
14.

Pitavastatin: an overview.

Saito Y.

Atheroscler Suppl. 2011 Nov;12(3):271-6. doi: 10.1016/S1567-5688(11)70886-8. Review.

PMID:
22152281
15.

Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study.

Cheung RC, Morrell JM, Kallend D, Watkins C, Schuster H.

Int J Cardiol. 2005 Apr 20;100(2):309-16.

PMID:
15823640
16.

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW; STELLAR Study Group.

Am J Cardiol. 2003 Jul 15;92(2):152-60.

PMID:
12860216
17.

Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.

Plans-RubiĆ³ P.

Am J Cardiovasc Drugs. 2006;6(3):177-88.

PMID:
16780391
18.

Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.

Davidson MH, Ose L, Frohlich J, Scott RS, Dujovne CA, Escobar ID, Bertolami MC, Cihon F, Maccubbin DL, Mercuri M.

Clin Cardiol. 2003 Nov;26(11):509-14. Review.

PMID:
14640465
19.

An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).

Smith DG, McBurney CR.

Pharmacoeconomics. 2003;21 Suppl 1:13-23.

PMID:
12648031
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk